Related Experiment Videos
Hepatitis B virus contains pre-S gene-encoded domains
Nature
|May 9, 1985
Summary
Hepatitis B virus (HBV) envelope proteins, including pre-S sequences, are present in HBV particles. These pre-S proteins are immunogenic and recognized by liver cells, suggesting their importance in HBV vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- The hepatitis B virus (HBV) env gene encodes viral envelope proteins.
- Three related proteins can be coded by the env gene: S-protein, pre-S protein, and pre-S + S protein.
Purpose of the Study:
- To investigate the presence and properties of pre-S sequences in HBV particles.
- To evaluate the immunogenicity and diagnostic potential of pre-S synthetic peptides.
- To assess the role of pre-S proteins in liver cell recognition and potential inclusion in HBV vaccines.
Main Methods:
- Synthesis of peptides from the N-terminals of pre-S proteins.
- Generation of antisera against pre-S peptides.
- Analysis of HBV particles for the presence of env encoded proteins.
- Evaluation of antibody responses in human sera and after immunization.
Main Results:
- Unambiguous evidence for the presence of all three env encoded proteins (S, pre-S, pre-S + S) in HBV particles.
- Synthetic pre-S peptides are highly immunogenic and useful for detecting HBV-specific antibodies in human sera.
- Antibodies specific for pre-S determinants are elicited during natural HBV infection and by immunization.
- Current US-licensed HBV vaccine lacks pre-S proteins.
- HBV pre-S proteins possess domains recognized by liver cells.
Conclusions:
- Pre-S determinants are present in HBV particles and elicit specific immune responses.
- Pre-S proteins are important for liver cell recognition and may play a role in virus neutralization.
- The inclusion of pre-S proteins in HBV vaccines warrants consideration for enhanced efficacy.